Jodi Segal, MD, MPH

Johns Hopkins University, School of Medicine, Division of General Internal of Medicine

Poster(s):

• (051) Assessment of Risk-Benefit Balance of Immune Checkpoint Inhibitors in a Real-World Lung Cancer Population
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (134) A review of recommendations in guidelines on missing data in prediction modelling
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST